Weibing Miao

1.3k total citations
64 papers, 799 citations indexed

About

Weibing Miao is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Weibing Miao has authored 64 papers receiving a total of 799 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Oncology, 27 papers in Radiology, Nuclear Medicine and Imaging and 17 papers in Surgery. Recurrent topics in Weibing Miao's work include Peptidase Inhibition and Analysis (32 papers), Radiopharmaceutical Chemistry and Applications (19 papers) and Protease and Inhibitor Mechanisms (15 papers). Weibing Miao is often cited by papers focused on Peptidase Inhibition and Analysis (32 papers), Radiopharmaceutical Chemistry and Applications (19 papers) and Protease and Inhibitor Mechanisms (15 papers). Weibing Miao collaborates with scholars based in China, Singapore and United States. Weibing Miao's co-authors include Shaobo Yao, Jiaying Zhang, Zhenying Chen, Qianqian Xue, Jie Zang, Jiaying Zhang, Yun Chen, Zhaohui Zhu, Bing Jia and Chao Huang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Biomaterials.

In The Last Decade

Weibing Miao

58 papers receiving 796 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weibing Miao China 16 480 291 228 214 137 64 799
Haili Su China 11 155 0.3× 271 0.9× 236 1.0× 173 0.8× 335 2.4× 19 909
Markus Niemeyer Germany 14 208 0.4× 375 1.3× 220 1.0× 218 1.0× 223 1.6× 18 948
Shozo Yokoyama Japan 21 888 1.9× 161 0.6× 552 2.4× 157 0.7× 347 2.5× 84 1.5k
Gilbert Mühlmann Austria 15 297 0.6× 190 0.7× 383 1.7× 86 0.4× 259 1.9× 22 1.0k
Mitsutaka Sugita Japan 16 196 0.4× 142 0.5× 421 1.8× 106 0.5× 262 1.9× 48 1.1k
Coen I.M. Baeten Netherlands 12 397 0.8× 110 0.4× 282 1.2× 100 0.5× 176 1.3× 20 769
Julie Steinestel Germany 19 304 0.6× 81 0.3× 229 1.0× 306 1.4× 351 2.6× 42 1.0k
Christoph Wiltschke Austria 15 679 1.4× 287 1.0× 77 0.3× 121 0.6× 243 1.8× 32 1.0k
Yan Monnier Switzerland 16 266 0.6× 97 0.3× 259 1.1× 113 0.5× 211 1.5× 31 774
Shigenori Nagata Japan 16 475 1.0× 75 0.3× 317 1.4× 155 0.7× 148 1.1× 68 857

Countries citing papers authored by Weibing Miao

Since Specialization
Citations

This map shows the geographic impact of Weibing Miao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weibing Miao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weibing Miao more than expected).

Fields of papers citing papers by Weibing Miao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weibing Miao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weibing Miao. The network helps show where Weibing Miao may publish in the future.

Co-authorship network of co-authors of Weibing Miao

This figure shows the co-authorship network connecting the top 25 collaborators of Weibing Miao. A scholar is included among the top collaborators of Weibing Miao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weibing Miao. Weibing Miao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Meng, L., Jingru Zhang, Huifeng Li, et al.. (2025). Modification of Asp–Peptide Adapters: Giving the FAP-Targeted Radioligand a “Squirrel Tail”. Journal of Medicinal Chemistry. 68(6). 6576–6587. 3 indexed citations
3.
Zang, Jie, Hongfei Cheng, Yang Luo, et al.. (2025). First-in-human study of a novel bifunctional PET tracer [68Ga]Ga-DOTA-NI-FAPI-04 targeting FAP and hypoxia. European Journal of Nuclear Medicine and Molecular Imaging. 53(4). 2530–2539.
4.
Chen, Zhenying, Ai−Hong Chen, Junfang Lin, et al.. (2024). [68Ga]Pentixafor PET/CT for staging and prognostic assessment of newly diagnosed multiple myeloma: comparison to [18F]FDG PET/CT. European Journal of Nuclear Medicine and Molecular Imaging. 51(7). 1926–1936. 5 indexed citations
5.
Chen, Yun, Jie Zang, Daniel C. Tu, et al.. (2024). [68Ga]Ga-LNC1007 versus 2-[18F]FDG in the evaluation of patients with metastatic differentiated thyroid cancer: a head-to-head comparative study. European Journal of Nuclear Medicine and Molecular Imaging. 52(2). 683–692. 2 indexed citations
6.
Zheng, Jieling, Guochang Wang, Yun Yang, et al.. (2024). A head-to-head comparison of [68Ga]Ga-DOTATATE and [68Ga]Ga-FAPI PET/CT in patients with nasopharyngeal carcinoma: a single-center, prospective study. European Journal of Nuclear Medicine and Molecular Imaging. 51(11). 3386–3399. 3 indexed citations
7.
Zheng, Jieling, et al.. (2024). 68Ga-FAPI PET/CT Depicted the Fibrosis of Ischemic Colitis. Clinical Nuclear Medicine. 49(11). 1050–1052. 3 indexed citations
8.
Zang, Jie, Shaoming Chen, Chao Wang, et al.. (2024). Diagnostic Performance of [18F]AlF-Thretide PET/CT in Patients with Newly Diagnosed Prostate Cancer Using Histopathology as Reference Standard. Journal of Nuclear Medicine. 65(7). 1021–1026. 3 indexed citations
9.
Zang, Jie, Xuejun Wen, Chao Wang, et al.. (2023). A Head-to-Head Comparison of 68Ga-LNC1007 and 2-18F-FDG/68Ga-FAPI-02 PET/CT in Patients With Various Cancers. Clinical Nuclear Medicine. 48(10). 861–868. 11 indexed citations
10.
Chen, Shao‐Hao, Shaoming Chen, Yong Wei, et al.. (2023). Head-to-head comparisons of 68Ga-PSMA-11 and 18F-FDG PET/CT in evaluating patients with upper tract urothelial carcinoma: a prospective pilot study. International Urology and Nephrology. 55(11). 2753–2764. 3 indexed citations
11.
Chen, Shao‐Hao, Shaoming Chen, Yong Wei, et al.. (2023). Head-to-head comparisons of enhanced CT, 68Ga-PSMA-11 PET/CT and 18F-FDG PET/CT in identifying adverse pathology of clear-cell renal cell carcinoma: a prospective study. International braz j urol. 49(6). 716–731. 5 indexed citations
12.
Zang, Jie, Guochang Wang, Tianzhi Zhao, et al.. (2023). A phase 1 trial to determine the maximum tolerated dose and patient-specific dosimetry of [177Lu]Lu-LNC1003 in patients with metastatic castration-resistant prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 51(3). 871–882. 16 indexed citations
13.
Chen, Shaoming, Zhenying Chen, Ke Zheng, et al.. (2022). Accurate preoperative staging with [68Ga]Ga-FAPI PET/CT for patients with oral squamous cell carcinoma: a comparison to 2-[18F]FDG PET/CT. European Radiology. 32(9). 6070–6079. 27 indexed citations
14.
Zheng, Jieling, et al.. (2021). [68Ga]Ga-FAPI and [18F]FDG PET/CT images in a patient with juvenile polymyositis. European Journal of Nuclear Medicine and Molecular Imaging. 48(6). 2051–2052. 8 indexed citations
15.
Zhang, Ying, Jiawei Cai, Zanyi Wu, Shaobo Yao, & Weibing Miao. (2021). Intense [68Ga]Ga-FAPI-04 uptake in solitary fibrous tumor/hemangiopericytoma of the central nervous system. European Journal of Nuclear Medicine and Molecular Imaging. 48(12). 4103–4104. 7 indexed citations
16.
Zhang, Duo, P. Hendrik Pretorius, Weibing Miao, et al.. (2021). A novel deep-learning–based approach for automatic reorientation of 3D cardiac SPECT images. European Journal of Nuclear Medicine and Molecular Imaging. 48(11). 3457–3468. 13 indexed citations
17.
Xue, Qianqian & Weibing Miao. (2020). Inflammatory Pseudotumor of Intestine Mimicking Lymphoma on 18F-FDG PET/CT. Clinical Nuclear Medicine. 45(5). 383–384. 6 indexed citations
18.
Zheng, Jieling, et al.. (2017). Evaluation of 99mTc-3PRGD2 integrin receptor imaging in hepatocellular carcinoma tumour-bearing mice: comparison with 18F-FDG metabolic imaging. Annals of Nuclear Medicine. 31(6). 486–494. 5 indexed citations
19.
Huang, Chao, et al.. (2015). Study of novel molecular probe 99mTc-3PRGD2 in the diagnosis of rheumatoid arthritis. Nuclear Medicine Communications. 36(12). 1208–1214. 8 indexed citations
20.
Fine, Eugene J., Weibing Miao, Wade Koba, Jeff S. Volek, & M. Donald Blaufox. (2009). Chronic effects of dietary carbohydrate variation on [18F]-2-fluoro-2-deoxyglucose uptake in rodent heart. Nuclear Medicine Communications. 30(9). 675–680. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haili Su Breakdown of academic impact, for papers by Markus Niemeyer Breakdown of academic impact, for papers by Shozo Yokoyama Breakdown of academic impact, for papers by Gilbert Mühlmann Breakdown of academic impact, for papers by Mitsutaka Sugita Breakdown of academic impact, for papers by Coen I.M. Baeten Breakdown of academic impact, for papers by Julie Steinestel Breakdown of academic impact, for papers by Christoph Wiltschke Breakdown of academic impact, for papers by Yan Monnier Breakdown of academic impact, for papers by Shigenori Nagata
Rankless by CCL
2026